Mission Statement Physicians dedicated to improving the treatment of substance use disorders. A State chapter of the American Society of Addiction Medicine.
Continuing Medical Education

Essentials of Addiction Medicine

August 24-27, 2016 | Anaheim Marriott • Anaheim, California

This conference is one of the nation’s foremost annual gatherings of physicians and other healthcare professionals who specialize in the treatment of Substance Use Disorders (SUD) and practicing physicians in both primary care and other specialty fields who are seeking an overview of the field of Addiction Medicine.


 

Addiction Medicine Now ABMS Recognized

March 14, 2016 -- The American Board of Medical Specialties (ABMS) has officially recognized Addiction Medicine as a subspecialty. The American Board of Preventive Medicine (ABPM), a Member Board of ABMS, sponsored the application for the new field to be a multispecialty subspecialty.  Certification by an ABMS is considered the “gold standard” in physician credentialing, assuring patients that their physician meets the highest standards of practice and clinical knowledge, and has completed an approved educational program and process.

As part of the transition there will not be a Addiction Medicine Certification Exam in 2016. CSAM will offer Essentials of Addiction Medicine Course August 24-27, 2016 in Anaheim.  This Course will feature nationally-recognized experts and is designed to prepare attendees for future Addiction Medicine Boards, provide a framework for those wanting to integrate addiction treatment into their primary care practice, and offer a refresher for experienced addiction medicine practitioners.

FAQ on ABMS Recognition

Available on the Online Education Center

Online Synapse to Society: Addiction Medicine State of the Art 2015

Held October 24-27 in San Francisco
27 lectures 16.5 AMA/PRA Category 1 Credits
more information

Addiction Medicine Review Course and Certification Exam Preparation Track

Held September 3-6, 2014 in Anaheim
Review Course 16.5 AMA/PRA Category 1 Credits
Certification Exam Preparation Track 17 AMA/PRA Category 1 Credits
more information

Public Policy

CSAM Cannabis Policy Statements

An initiative to legalize cannabis is highly likely to appear on the 2016 California ballot. In the advent of policy changes that may increase availability of cannabis, an addictive drug, what are credible and evidence-based positions that prevent addiction, prevent harm to vulnerable populations, and promote access to quality treatment? CSAM believes that it is not necessary to support an initiative to work toward ensuring that whatever initiative is presented or eventually adopted takes measures to mitigate public health harms associated with expanded access to and use of cannabis.

  • CSAM has established recommendations for cannabis policy in the prospect of possible ballot initiatives legalizing cannabis in California. [Read CSAM recommendations]
  • The Control. Regulate and Tax Adult Use of Marijuana Act (Initiative No. 15-0103) is one of several initiatives that are seeking a place on the 2016 ballot.  CSAM has submitted comments to the initiative's drafters through the California Attorney General's Office. [Read CSAM comments]  

Minimum Insurance Benefits for Medically-Assisted Treatment of Opioid Dependence

CSAM’s Consumer Guide and Scorecard rating Covered California health plans on coverage for addiction treatment, published last year disclosed that not a single health plan offered the minimum health insurance coverage for medically-assisted treatment of opioid dependence. In most plans physicians were not allowed to choose the appropriate medication, with plans offering either methadone OR buprenorphine. Many plans also required physicians to provide extensive paperwork every month for on-going treatment.  CSAM’s Committee on opioids will be advocating that ALL insurance plans meet these standards by meeting with insurance regulators and insurance companies.  As part of this Committee members Tauheed Zaman, MD and Joan Striebel, MD drafted a report that describes the minimum benefits insurance companies should provide to meet standards of evidence-based practice.